Page last updated: 2024-08-24

gemcitabine and Cancer of Cervix

gemcitabine has been researched along with Cancer of Cervix in 64 studies

Research

Studies (64)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.13)	18.2507
2000's	32 (50.00)	29.6817
2010's	26 (40.63)	24.3611
2020's	4 (6.25)	2.80

Authors

Authors	Studies
Cheng, XR; Liu, RF; Zou, MJ	1
Abdo Filho, E; Aranha, AS; Bonadio, RC; Carvalho, HA; da Costa, SCS; de Freitas, D; Dias Genta, MLN; Estevez-Diz, MDP; Ferreira, PAO; Gabrielli, FCG; Machado, KK; Miranda, VC; Scaranti, M	1
Bonadio, R; da Costa, S; de Bock, GH; Del Pilar Estevez Diz, M; Dornellas, A; Nunes de Arruda, F; Pereira, D	1
Aps, LRMM; Bitencourt Rodrigues, K; Cestari Moreno, N; de Oliveira Diniz, M; de Oliveira Silva, M; de Souza Ferreira, LC; Menck, CFM; Porchia, BFMM; Ramos da Silva, J; Ramos Moreno, AC; Silva Sales, N; Venceslau-Carvalho, AA	1
Arango-Bravo, E; Brau-Figueroa, H; Castro-Eguiluz, D; Cetina-Pérez, L; Cruz-Bautista, I; Galicia-Carmona, T; Jiménez-Lima, R; Lugo-Alferez, LA	1
Behera, UC; Modi, RR; Sheth, J; Singh, A	1
Cantú, D; Cetina, L; Chanona, J; Coronel, J; de la Garza, J; Dueñas-González, A; González-Enciso, A; Hinojosa, J; Jiménez-Lima, R; Montalvo, G; Mota, A; Muñoz, D; Pérez-Montiel, D; Poitevin, A; Rivera, L; Robles-Flores, J; Serrano, A; Trejo, E; Wegman, T	1
Clements, A; Cohn, DE; Smith, B; Straughn, JM; Tierney, BJ	1
Akbari, EH; Esmati, E; Hashemi, FA; Kalaghchi, B	1
Jiang, Y; Yang, L; Yuan, Z; Zhang, Y; Zhao, Q	1
Eskander, RN; Tewari, KS	1
Katanyoo, K; Laopaiboon, M; Lumbiganon, P; Manusirivithaya, S; Supawattanabodee, B; Tangjitgamol, S	1
Chang, CJ; Chang, TC; Chen, CH; Chou, HH; Hong, JH; Huang, EY; Huang, HJ; Huang, KG; Lai, CH; Lin, H; Liou, JD; Liou, WS; Liu, FY; Tseng, CW; Wang, CC; Yang, LY	1
Akise, Y; Hashimoto, S; Kutsuki, S; Miyazawa, M; Nishimoto, K; Uchida, A	1
Bazan-Perkins, B; Candelaria, M; Cantú, D; Cetina, L; Coronel, J; Dueñas-González, A; Flores, V; Garcia-Arias, A; Gonzalez, A; Rivera, L	1
Benda, J; Boardman, CH; Cella, D; Cohn, DE; McMeekin, DS; Monk, BJ; Ramondetta, LM; Sill, MW	1
Chen, YG; Hu, JM; Huang, Q; Qu, QX; Xie, F; Zhang, XG	1
Eastwood, A; Manca, A; Misso, K; Palmer, S; Paton, F; Paulden, M; Saramago, P	1
Benda, J; Boardman, CH; Cella, D; Cohn, D; Huang, HQ; McMeekin, DS; Monk, BJ; Ramondetta, L; Wenzel, L	1
Ahmed, M; Hassan, AH; Hussain, A; Priyani, A; Sadrieh, L; Sharma, C	1
Ahmed, M; Brahmbhatt, K; Hussain, A; Priyani, A; Sadrieh, L; Sharma, C	1
Thomas, G	1
Alcedo, JC; Barraclough, H; Beslija, S; Blair, JM; Casanova, L; Dueñas-González, A; Hameed, S; Orlando, M; Patel, F; Pattaranutaporn, P; Zarbá, JJ	1
Chan, S; Davidson, SE; Harden, S; McMahon, T; Paul, J; Rai, D; Reed, NS; Symonds, RP	1
Ahmed, M; Brahmbhatt, K; Hussain, A; Priyani, A; Rizvi, TA; Sharma, C	1
Cetina, L; Coronel, J; Dueñas-Gonzalez, A	1
Orlova, RV; Protasova, AE	1
Candelaria, M; Chavez-Blanco, A; de la Cruz-Hernandez, E; Diaz-Chavez, J; Dominguez, G; Duenas-Gonzalez, A; Gonzalez-Fierro, A; Perez-Cardenas, E; Soto-Reyes, E; Taja-Chayeb, L; Trejo-Becerril, C; Trujillo, JE	1
Barraclough, H; Dueňas-González, A; Orlando, M; Quinlivan, M; Zhou, Y	1
Barnett, JC; Chino, JP; Havrilesky, LJ; Jewell, EL; Leath, CA; Phippen, NT	1
O'Malley, DM; Salani, R	1
Markman, M	1
Chanona, G; De La Garza, J; Duenas-Gonzalez, A; Gonzalez-Enciso, A; Guadarrama, R; Lopez-Graniel, C; Mohar, A; Mota, A; Rivera, L	1
Barsoum, J; Brickelmaier, M; Carmillo, A; Goelz, S; Qin, XQ	1
Clippe, C; Ligneau, B; Trillet-Lenoir, V	1
Chanona, G; de la Garza, J; Dueñas-González, A; Gomez, E; González, A; López-Graniel, C; Mohar, A; Rivera, L; Trejo-Becerril, C	1
Chávez-Blanco, A; Dueñas-González, A; García-López, P; González-Fierro, A; Lizano-Soberon, M; Mariscal, I; Pérez-Cárdenas, E; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C; Treviño-Cuevas, H; Wegman-Ostrosky, T	1
Arroyo, G; Castagnino, R; Gonzalez Jazey, P; Jaremtchuk, AV; Keropian, M; Mina, C; Zarbá, JJ	1
Bloss, JD; Mutch, DG	1
Chitapanarux, I; Kamnerdsupaphon, P; Lorvidhaya, V; Sukthomya, V; Tonusin, A	1
Candelaria, M; Cetina, L; de la Garza, J; Dueñas-González, A; Rivera, L	1
Blessing, J; Cohn, DE; Schilder, RJ	1
Azria, D; Coelho, M; Culine, S; Dubois, JB; Larbouret, C; Lemanski, C; Pèlegrin, A; Serre, A; Ychou, M	1
Cetina-Perez, L; de La Garza, J; Dueñas-González, A; Gómez-Gonzalez, E; Gonzalez-Enciso, A; Lopez-Graniel, C; Mohar, A; Montalvo-Esquivel, G; Muñoz-Gonzalez, D; Rivera-Rubi, L; Robles-Flores, J; Vazquez-Govea, E	1
Lertkhachonsuk, R; Sirisabya, N; Sittisomwong, T; Termrungruanglert, W; Tresukosol, D; Vasuratna, A	1
Brom, R; Candelaria, M; Cantu, D; Cetina, L; Chanona, J; de la Garza, J; Dolores, R; Duenas-Gonzalez, A; Gonzalez, A; Lopez-Graniel, C; Uribe, J	1
Blessing, JA; Brewer, CA; Lele, S; McMeekin, DS; Nagourney, RA; Zweizig, SL	1
Aguiluz, M; Andrade, S; Erazo, M; Flores, C; Pineda, C; Santillana, S; Umanzor, J	1
Garcia, R; Goff, BA; Greer, B; Koh, WJ; Swensen, RE; Swisher, EM; Tamimi, H	1
Atkinson, T; Campos, S; Duska, L; Fuller, AF; Goodman, A; Krasner, CN; Matulonis, UA; Penson, RT; Seiden, MV; Verrill, C	1
Aimpun, P; Jarruwale, P; Tanapat, Y	1
Bae, DS; Choi, CH; Huh, SJ; Kim, BG; Kim, TJ; Kim, WY; Lee, JH; Lee, JW; Nam, HR	1
Degeest, K; Fusco, N; McMeekin, S; Rose, PG	1
Chumworathayi, B; Krusun, S; Luanratanakorn, S; Pattamadilok, J; Tangvorapongchai, V; Yuenyao, P	1
Eisenhauer, EA; Vermorken, JB	1
Fukuoka, M; Furuse, K; Hasegawa, K; Hirabayashi, K; Nakajima, H; Niitani, H; Noda, K; Ogura, T; Taguchi, T	1
Brader, KR; Burnett, AF; Garcia, AA; Morrow, CP; Muderspach, LI; Roman, LD	1
Blessing, JA; Mangan, CE; Morgan, M; Rader, JS; Schilder, RJ	1
D'Agostino, G; Genovesi, D; Greggi, S; Lorusso, D; Scambia, G; Smaniotto, D	1
de la Guerra, J; Dueñas-Gonzalez, A; Hinojosa-García, LM; López-Graniel, C; Maldonado, V; Meléndez-Zagla, J	1
Chansilpa, Y; Ieumwananontachai, N; Pattaranutaporn, P; Thephamongkhol, K; Therasakvichya, S; Thirapakawong, C	1
Chanona, J; De la Garza, J; Dueñas-Gonzalez, A; Florentino, R; Gonzalez, A; Guadarrama, R; Hinojosa, LM; Lopez-Graniel, C; Maldonado, V; Meléndez, J; Mohar, A; Mota, A; Muñoz, D; Reyes, M; Robles, E; Solorza, G	1
Dueñas-Gonzalez, A; Hernández, P; Maldonado, V; Meléndez-Zajgla, J; Olivera, P; Pérez-Pastenes, MA; Zárate, A	1
Bagrova, SG	1

Reviews

9 review(s) available for gemcitabine and Cancer of Cervix

Article	Year
Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer. Current opinion in obstetrics & gynecology, 2014, Volume: 26, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Mass Screening; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Taxoids; Topotecan; Uterine Cervical Neoplasms	2014
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer. The Cochrane database of systematic reviews, 2014, Dec-03, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Mitomycin; Neoplasm Staging; Randomized Controlled Trials as Topic; Uterine Cervical Neoplasms	2014
Topotecan for the treatment of recurrent and stage IVB carcinoma of the cervix. Health technology assessment (Winchester, England), 2010, Volume: 14 Suppl 1 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cost-Benefit Analysis; Cross-Linking Reagents; Deoxycytidine; Disease Progression; Drug Therapy, Combination; Female; Gemcitabine; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Quality of Life; Quality-Adjusted Life Years; Radiation-Sensitizing Agents; Topotecan; Treatment Outcome; United Kingdom; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine	2010
Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer. Expert opinion on drug metabolism & toxicology, 2011, Volume: 7, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Neoplasm Metastasis; Paclitaxel; Radiation-Sensitizing Agents; Survival Rate; Topotecan; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine	2011
Chemoradiation in the management of cervix cancer: current status and future directions. Oncology, 2013, Volume: 84, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Uterine Cervical Neoplasms	2013
[Role of gemcitabine in the treatment of other malignant tumors]. Bulletin du cancer, 2002, Volume: 89 Spec No Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Female; Gastrointestinal Diseases; Gastrointestinal Neoplasms; Gemcitabine; Hematologic Diseases; Humans; Lung Neoplasms; Melanoma; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Treatment Outcome; Uterine Cervical Neoplasms	2002
Gemcitabine in cervical cancer. Gynecologic oncology, 2003, Volume: 90, Issue:2 Pt 2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxycytidine; Female; Gemcitabine; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms	2003
[Concomitant use of radiotherapy and gemcitabine: preclinical findings and clinical practice]. Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2004, Volume: 8 Suppl 1 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Mice; Neoplasms; Otorhinolaryngologic Neoplasms; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Rats; Time Factors; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	2004
New drugs in gynecologic oncology. Current opinion in oncology, 1996, Volume: 8, Issue:5 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Squamous Cell; Clinical Trials as Topic; Deoxycytidine; Endometrial Neoplasms; Female; Gemcitabine; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Platinum Compounds; Uterine Cervical Neoplasms	1996

Trials

34 trial(s) available for gemcitabine and Cancer of Cervix

Article	Year
Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019, 11-20, Volume: 37, Issue:33 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Patient Compliance; Progression-Free Survival; Uterine Cervical Neoplasms; Young Adult	2019
Quality of life of locally advanced cervical cancer patients after neoadjuvant chemotherapy followed by chemoradiation versus chemoradiation alone (CIRCE trial): a randomized phase II trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020, Volume: 30, Issue:6 Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Quality of Life; Uterine Cervical Neoplasms	2020
Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: a randomized, phase III study in IB2-IIB cervical cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:8 Topics: Adult; Aged; Brachytherapy; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Hysterectomy; Middle Aged; Radiation-Sensitizing Agents; Survival; Treatment Outcome; Uterine Cervical Neoplasms; Young Adult	2013
[ATP-tumor chemosensitivity assay directed chemotherapy in patients with cervical cancer]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2013, Volume: 38, Issue:12 Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Deoxycytidine; Drug Screening Assays, Antitumor; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Neoplasm Recurrence, Local; Paclitaxel; Survival Rate; Uterine Cervical Neoplasms; Vincristine	2013
A randomized trial comparing concurrent chemoradiotherapy with single-agent cisplatin versus cisplatin plus gemcitabine in patients with advanced cervical cancer: An Asian Gynecologic Oncology Group study. Gynecologic oncology, 2015, Volume: 137, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms	2015
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Oct-01, Volume: 27, Issue:28 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Fatigue; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Leukopenia; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neutropenia; Paclitaxel; Prognosis; Quality of Life; Topotecan; Treatment Outcome; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine; Young Adult	2009
Health-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study. Gynecologic oncology, 2010, Volume: 119, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Topotecan; Treatment Outcome; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine	2010
Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, May-01, Volume: 29, Issue:13 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Infant; Infant, Newborn; Uterine Cervical Neoplasms	2011
SCOTCERV: a phase II trial of docetaxel and gemcitabine as second line chemotherapy in cervical cancer. Gynecologic oncology, 2011, Volume: 123, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Docetaxel; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Quality of Life; Taxoids; Uterine Cervical Neoplasms	2011
Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chemoradiotherapy plus adjuvant gemcitabine and cisplatin: prognostic and predictive factors and the impact of disease stage on outcomes from a prospective Gynecologic oncology, 2012, Volume: 126, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Squamous Cell; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Lymph Nodes; Middle Aged; Neoplasm Staging; Proportional Hazards Models; Tumor Burden; Uterine Cervical Neoplasms	2012
Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix. Gynecologic oncology, 2012, Volume: 127, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Female; Gemcitabine; Humans; Markov Chains; Middle Aged; Models, Statistical; Neoplasm Staging; Quality of Life; Quality-Adjusted Life Years; Survival Analysis; Treatment Outcome; United States; Uterine Cervical Neoplasms	2012
Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms	2002
Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma. American journal of clinical oncology, 2003, Volume: 26, Issue:1 Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Uterine Cervical Neoplasms	2003
A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Confidence Intervals; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gemcitabine; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms	2003
Cisplatin and gemcitabine in patients with metastatic cervical cancer. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Survival Rate; Thrombocytopenia; Uterine Cervical Neoplasms	2004
Chemoradiation with gemcitabine for cervical cancer in patients with renal failure. Anti-cancer drugs, 2004, Volume: 15, Issue:8 Topics: Brachytherapy; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Creatinine; Deoxycytidine; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Gemcitabine; Humans; Injections, Intravenous; Kidney Function Tests; Mexico; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Renal Insufficiency; Time Factors; Treatment Outcome; Urethral Obstruction; Uterine Cervical Neoplasms	2004
Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecologic oncology, 2005, Volume: 96, Issue:1 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Carcinoma, Adenosquamous; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms	2005
Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study. International journal of radiation oncology, biology, physics, 2005, Mar-01, Volume: 61, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Confidence Intervals; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Radiation-Sensitizing Agents; Radiotherapy Dosage; Uterine Cervical Neoplasms	2005
Neoadjuvant gemcitabine and cisplatin followed by radical surgery in (bulky) squamous cell carcinoma of cervix stage IB2. Gynecologic oncology, 2005, Volume: 97, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Uterine Cervical Neoplasms	2005
Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Gynecologic oncology, 2006, Volume: 100, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms	2006
Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial. Gynecologic oncology, 2006, Volume: 100, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Uterine Cervical Neoplasms	2006
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium. Gynecologic oncology, 2006, Volume: 101, Issue:3 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Uterine Cervical Neoplasms	2006
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. Gynecologic oncology, 2006, Volume: 103, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dose-Response Relationship, Drug; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms	2006
Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: preliminary results. International journal of radiation oncology, biology, physics, 2007, Jul-01, Volume: 68, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Comorbidity; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Diseases; Gemcitabine; Humans; Incidence; Korea; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms	2007
A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study. Gynecologic oncology, 2007, Volume: 107, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Feasibility Studies; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Pelvis; Radiotherapy, Adjuvant; United States; Uterine Cervical Neoplasms	2007
Weekly gemcitabine and cisplatin concurrent with pelvic irradiation for primary therapy of cervical cancer: report of the first seven cases in Thai women. Radiation medicine, 2007, Volume: 25, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Middle Aged; Thailand; Treatment Outcome; Uterine Cervical Neoplasms	2007
[An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II]. Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Breast Neoplasms; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Stomach Neoplasms; Uterine Cervical Neoplasms	1996
A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecologic oncology, 2000, Volume: 76, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Cervical Neoplasms	2000
Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: a Phase II study of the gynecologic oncology group. Gynecologic oncology, 2000, Volume: 76, Issue:2 Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Uterine Cervical Neoplasms	2000
Gemcitabine is ineffective in recurrent, preirradiated cervical cancer. Gynecologic oncology, 2000, Volume: 78, Issue:1 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Disease-Free Survival; Female; Gemcitabine; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neoplasm Recurrence, Local; Treatment Outcome; Uterine Cervical Neoplasms	2000
Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma. American journal of clinical oncology, 2001, Volume: 24, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Uterine Cervical Neoplasms	2001
Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma. Gynecologic oncology, 2001, Volume: 81, Issue:3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Humans; Middle Aged; Neoplasm Staging; Radiation-Sensitizing Agents; Radiotherapy; Uterine Cervical Neoplasms	2001
A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:4 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms	2001
[Results of phase II clinical trial of cycloplatam in refractory solid tumors]. Voprosy onkologii, 2001, Volume: 47, Issue:6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mesothelioma; Middle Aged; Organoplatinum Compounds; Pleural Neoplasms; Pleurisy; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Vinblastine; Vinorelbine	2001

Other Studies

21 other study(ies) available for gemcitabine and Cancer of Cervix

Article	Year
lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF. The journal of obstetrics and gynaecology research, 2022, Volume: 48, Issue:7 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Discs Large Homolog 1 Protein; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Nude; MicroRNAs; RNA, Long Noncoding; Uterine Cervical Neoplasms	2022
A therapeutic DNA vaccine and gemcitabine act synergistically to eradicate HPV-associated tumors in a preclinical model. Oncoimmunology, 2021, Volume: 10, Issue:1 Topics: Alphapapillomavirus; Animals; CD8-Positive T-Lymphocytes; Deoxycytidine; Female; Gemcitabine; Humans; Mice; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Uterine Cervical Neoplasms; Vaccines, DNA	2021
Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities. Cancer research and treatment, 2022, Volume: 54, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Uterine Cervical Neoplasms	2022
Bilateral macular infarction after gemcitabine and carboplatin chemotherapy. International ophthalmology, 2018, Volume: 38, Issue:5 Topics: Adult; Antimetabolites, Antineoplastic; Carboplatin; Deoxycytidine; Drug Therapy, Combination; Female; Gemcitabine; Humans; Infarction; Macula Lutea; Retinal Diseases; Uterine Cervical Neoplasms; Visual Acuity	2018
Is the progression free survival advantage of concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in patients with advanced cervical cancer worth the additional cost? A cost-effectiveness analysis. Gynecologic oncology, 2013, Volume: 130, Issue:3 Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Cost-Benefit Analysis; Deoxycytidine; Disease-Free Survival; Female; Gemcitabine; Hospitalization; Humans; Models, Econometric; Neutropenia; Uterine Cervical Neoplasms	2013
Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Cobalt Radioisotopes; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Uterine Cervical Neoplasms; Young Adult	2013
A Case of Severe Rectal Hemorrhage Possibly Caused by Radiation Recall after Administration of Gemcitabine. The Keio journal of medicine, 2016, Volume: 65, Issue:1 Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Deoxycytidine; Female; Gamma Rays; Gastrointestinal Hemorrhage; Gemcitabine; Humans; Radiation-Sensitizing Agents; Radiodermatitis; Rectum; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms	2016
Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients. World journal of surgical oncology, 2009, Feb-16, Volume: 7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Hysterectomy; Lymph Nodes; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Treatment Outcome; Uterine Cervical Neoplasms	2009
Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma. Medical oncology (Northwood, London, England), 2011, Volume: 28, Issue:3 Topics: Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; CD40 Antigens; Cell Line, Tumor; Cell Proliferation; Cell Separation; Deoxycytidine; Enzyme Activation; Female; Flow Cytometry; Gemcitabine; Humans; Immunohistochemistry; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Uterine Cervical Neoplasms	2011
Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells. Cancer epidemiology, 2011, Volume: 35, Issue:3 Topics: Anticarcinogenic Agents; Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cyclooxygenase 2; Deoxycytidine; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Inflammation; Interleukin-1beta; Isothiocyanates; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; Sulfoxides; Thiocyanates; Uterine Cervical Neoplasms	2011
Concurrent sulforaphane and eugenol induces differential effects on human cervical cancer cells. Integrative cancer therapies, 2012, Volume: 11, Issue:2 Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Deoxycytidine; Down-Regulation; Drug Synergism; Eugenol; Female; Gemcitabine; HeLa Cells; Humans; Interleukin-1beta; Isothiocyanates; Proto-Oncogene Proteins c-bcl-2; Sulfoxides; Thiocyanates; Tumor Cells, Cultured; Uterine Cervical Neoplasms	2012
Are we making progress in curing advanced cervical cancer? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, May-01, Volume: 29, Issue:13 Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Deoxycytidine; Developing Countries; Female; Gemcitabine; Humans; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Uterine Cervical Neoplasms	2011
Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer biotherapy & radiopharmaceuticals, 2011, Volume: 26, Issue:5 Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Synergism; Eugenol; Female; Gemcitabine; HeLa Cells; Humans; Uterine Cervical Neoplasms	2011
[Results of chemotherapy for gynecologic cancer patients in ambulatory care]. Voprosy onkologii, 2011, Volume: 57, Issue:4 Topics: Ambulatory Care; Ambulatory Care Facilities; Anemia, Hypochromic; Antineoplastic Agents; Carboplatin; Cisplatin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Endometrial Neoplasms; Female; Gemcitabine; Genital Neoplasms, Female; Hospitalization; Humans; Middle Aged; Neutropenia; Outpatients; Ovarian Neoplasms; Paclitaxel; Quality of Life; Russia; Thrombocytopenia; Treatment Outcome; Uterine Cervical Neoplasms	2011
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells. PloS one, 2012, Volume: 7, Issue:3 Topics: Antimetabolites, Antineoplastic; Blotting, Western; Cell Culture Techniques; Cell Line, Tumor; Chromatin Immunoprecipitation; Deoxycytidine; DNA Primers; Drug Resistance, Neoplasm; Epigenesis, Genetic; Equilibrative Nucleoside Transporter 1; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone Deacetylases; Histone-Lysine N-Methyltransferase; Humans; Hydralazine; Reverse Transcriptase Polymerase Chain Reaction; Uterine Cervical Neoplasms	2012
Here it comes....the role of cost-effective analysis. Gynecologic oncology, 2012, Volume: 127, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Uterine Cervical Neoplasms	2012
Cytotoxicity of combinations of IFN-beta and chemotherapeutic drugs. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2002, Volume: 22, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Death; Cell Division; Cisplatin; Deoxycytidine; Drug Synergism; Female; Fluorouracil; Gemcitabine; Humans; Interferon-beta; Lung Neoplasms; Paclitaxel; Tumor Cells, Cultured; Uterine Cervical Neoplasms	2002
Circulating nucleosomes and response to chemotherapy: an in vitro, in vivo and clinical study on cervical cancer patients. International journal of cancer, 2003, May-10, Volume: 104, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Deoxycytidine; DNA, Neoplasm; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Female; Gemcitabine; HeLa Cells; Humans; In Vitro Techniques; Mice; Mice, Nude; Middle Aged; Neoadjuvant Therapy; Neoplastic Cells, Circulating; Nucleosomes; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Rats; Rats, Wistar; Tumor Virus Infections; Uterine Cervical Neoplasms	2003
Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer. BMC cancer, 2005, Sep-19, Volume: 5 Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Area Under Curve; Carboplatin; Cisplatin; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Gemcitabine; Humans; Middle Aged; Neoplasm Recurrence, Local; Pelvic Exenteration; Pilot Projects; Recurrence; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Uterine Cervical Neoplasms	2005
Gemcitabine and radiotherapy in the treatment of uterine cervical cancer patients at Phramongkutklao Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88 Suppl 3 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma; Combined Modality Therapy; Deoxycytidine; Female; Gemcitabine; Humans; Middle Aged; Retrospective Studies; Survival Rate; Thailand; Treatment Outcome; Uterine Cervical Neoplasms	2005
Gemcitabine activity in cervical cancer cell lines. Cancer chemotherapy and pharmacology, 2001, Volume: 48, Issue:6 Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Survival; Cisplatin; Deoxycytidine; DNA Damage; Drug Interactions; Female; Gemcitabine; HeLa Cells; Humans; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms	2001